5 Breast Cancer Clinical Trials in Daphne, AL (2026)

Q: How do I join a clinical trial in Daphne?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Daphne research site will contact you.

Recruiting Breast Cancer Studies in Daphne

NCT06492616Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal G...

Daphne, ALPHASE34,220 participantsStemline Therapeutics, Inc.

View Study Details

NCT06065748Recruiting

A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

This is a Phase III, randomized, open-label multicenter study that will evaluate the efficacy and safety of giredestrant compared with fulvestrant, both in combination with the investigator's choice o...

Daphne, ALPHASE31,050 participantsHoffmann-La Roche

View Study Details

NCT07060807Recruiting

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Researchers are looking for other ways to treat breast cancer (BC) that is hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) and either unresectable locally a...

Daphne, ALPHASE31,000 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06103864Recruiting

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer

This is a Phase III, randomised, open-label, 3-arm, multicentre, international study assessing the efficacy and safety of Dato-DXd with or without durvalumab compared with investigator's choice chemot...

Daphne, ALPHASE3625 participantsAstraZeneca

View Study Details

NCT06966453Recruiting

A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

The purpose of this clinical study is to learn about the safety and effects of the study medicine (called disitamab vedotin) for the possible treatment of people with breast cancer that is hard to tre...

Daphne, ALPHASE1100 participantsPfizer

View Study Details

About Breast Cancer Clinical Trials in Daphne

Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.

There are currently 5 breast cancer clinical trials recruiting participants in Daphne, AL. These studies are seeking a combined 6,995 participants. Research is being sponsored by Stemline Therapeutics, Inc., Hoffmann-La Roche, Merck Sharp & Dohme LLC and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Breast Cancer Clinical Trials in Daphne — FAQ

Are there breast cancer clinical trials in Daphne?

Yes, there are 5 breast cancer clinical trials currently recruiting in Daphne, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Daphne?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Daphne research site will contact you about next steps.

Are clinical trials in Daphne free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Daphne studies also compensate for your time and travel.

What breast cancer treatments are being tested?

The 5 active trials in Daphne are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.

Data updated July 22, 2026 from ClinicalTrials.gov